News | Press Releases

December 2, 2013

Toshiba CT Delivers More Consistent Results with Its Adaptive Diagnostics Technology

Helps Eliminate Variability in Scanning with the Industry’s Best Solutions

CHICAGO, Dec. 2, 2013 – Lowering CT dose and improving workflow are not choices that clinicians should have to make, so Toshiba CT is putting customers first by providing the industry’s best solutions to solve these challenges. To make complex exams easier, lower dose and improve diagnostic accuracy and reproducibility, Toshiba is introducing its Adaptive Diagnostics CT technology.

Available on the Aquilion™ ONE, Aquilion ONE ViSION Edition and Aquilion PRIME, Toshiba’s Adaptive Diagnostics includes:

  • SURESubtractionTM has the ability to remove bone and calcium from data sets while allowing clinicians to view tumors or arteries at risk. Currently available for brain, bone, carotid and coronary artery (pending FDA clearance) exams.
  • Metal Artifact Reduction (MAR) (pending FDA clearance) removes streak artifacts in images due to metallic implants in the body.
  • SURECardioTM Prospective with arrhythmia detection is a unique application that dramatically lowers patient dose during coronary CTA exams using a helical acquisition technique to provide one continuous image instead of multiple images. It automatically detects and adjusts to patients with irregular heartbeats, providing quicker, more conclusive exam results.
  • Variable Helical Pitch (vHP) has the ability to automatically change an ECG-gated to a non-ECG-gated acquisition, reducing IV contrast and radiation dose. vHP can significantly reduce radiation dose over the use of a single-gated pitch setting.
  • Dual Energy (pending FDA clearance) uses two energies during one CT scan, providing clinicians with more data to help quantify and characterize anatomy and lesions. As a result, exam times and radiation dose are both reduced.

“Today’s healthcare environment is changing and there are new clinical challenges that our customers are facing,” says Satrajit Misra, senior director, CT Business Unit, Toshiba. “Adaptive Diagnostics is an example of how Toshiba develops technologies that meet the needs of providers today and in the future, giving them the tools to improve quality of care while reducing costs.”

Toshiba is showcasing its Aquilion product line and Adaptive Diagnostics technology at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Dec. 1–6, 2013 (Booth #7330, North Hall).

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at

About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.

Toshiba was founded in 1875, and today operates a global network of more than 590 consolidated companies, with 206,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$61 billion). Visit Toshiba’s web site at